Loading…
avatar for Steve Colgan

Steve Colgan

Pfizer Worldwide Research and Development
Senior Director in Global CMC
North Haven, CT

Dr. Colgan received his B.S. in Chemistry from the State University of  New York College at Cortland, a Masters in Forensic Chemistry from Northeastern University, and a Ph.D. in Analytical Chemistry from Northeastern University.

 

Steve joined Pfizer Central Research in Groton Connecticut 1987 and has been there ever since.  After spending 10 years in Analytical R&D, Steve joined Chemical R&D where he managed several groups including an Early Development Analytical Group, a LCMS shop, and a Release Laboratory.  Six years later he directed 5 groups in Pfizer’s Global Supply Chain including a microbiology lab, a Biologics testing lab, and several labs supporting API manufacturing.  In 2006, Steve joined Global CMC where he directs regulatory scientists and develops regulatory strategies.  Steve is a member of Pfizer’s Impurity and Stability Councils.  He has been a major contributor to 15 marketing applications and has over 40 publications.

 

Dr. Colgan was the Analytical and Pharmaceutical Quality programming chair for the 2008 and 2009 National Biotechnology Conference.  He was awarded the American Association of Pharmaceutical Sciences (AAPS) APQ service award in 2008 and was elected to the Executive Council of the APQ Section of the AAPS in 2009. Currently, Steve is member of the AAPS Stability Focus Group Steering Committee.   Steve is the chair of a newly formed IQ Consortium Working Group on Risk-Based Predictive Stability.   Steve was recognized in 2016 by Medicine Maker magazine as one of the “100 most influential people in drug development and manufacturing.”

 

Outside of work, Steve is President of the Billings Lake and Woods Association, a member of the North Stonington CT Conservation Commission, a Host Site Coordinator for Best Buddies International, and a University of Connecticut Certified Advanced Master Gardener.